Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human 160 kD Neurofilament Medium ELISA Kit (AC3121)
Cat.#: ASET-1710
Specifications
Description Human 160 kD Neurofilament Medium ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human 160 kD Neurofilament Medium concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 5.31 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 75-1200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2440 Rat Semaphorin 3A ELISA Kit (AC3851) Quantitative inquiry ASET-2011 Human Kappa Opioid Receptor ELISA Kit (AC3422) Quantitative inquiry ASET-1310 Human Fatty Acid Synthase ELISA Kit (AC2721) Quantitative inquiry ASET-1912 Rat NMDAR1 ELISA Kit (AC3323) Quantitative inquiry ASET-1842 Human VGluT1 ELISA Kit (AC3253) Quantitative inquiry ASET-1540 Human Thyroid Hormone Receptor alpha ELISA Kit (AC2951) Quantitative inquiry ASET-1858 Human HSD17B8 ELISA Kit (AC3269) Quantitative inquiry ASET-2047 Mouse CaSR ELISA Kit (AC3458) Quantitative inquiry ASET-2042 Human Ephrin A4 ELISA Kit (AC3453) Quantitative inquiry ASET-1650 Rat Estradiol ELISA Kit (AC3061) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket